CDMRP Ovarian Cancer Academy Early-Career Investigator Award 2026

CDMRP Ovarian Cancer Academy Early-Career Investigator Award 2026

Due Date: 09/15/2026

The FY26 Ovarian Cancer Academy – Early-Career Investigator Award (OCA-ECI), offered through the Congressionally Directed Medical Research Programs’ Ovarian Cancer Research Program, supports junior investigators pursuing independent careers in ovarian cancer research.

The award combines a four-year research project with intensive mentorship, networking, professional development, monthly Academy activities, and collaboration with other ovarian cancer researchers. Approximately $4.5 million is expected to support four awards, with each application eligible for up to $1.125 million in total costs over four years.

Eligibility Criteria

  • Applicants must be within 5 years of their last postdoctoral research position, clinical fellowship, or equivalent as of October 1, 2026.
  • Individuals who are still in a postdoctoral position or clinical fellowship at the full application deadline are not eligible.
  • Applicants may be either research scientists or physician-scientists.
  • The institution must provide approximately 50% protected time for ovarian cancer research and Ovarian Cancer Academy activities.
  • If the Designated Mentor is at another institution, an additional Other Mentor at the applicant’s institution must be included.
  • Foreign and U.S. organizations, including nonprofit, for-profit, public, and private organizations, are eligible.
  • There are no nationality or citizenship restrictions for the PI.

Funding Details

  • Maximum award: $1.125 million in total costs.
  • Maximum duration: 4 years.
  • Total anticipated program funding: Approximately $4.5 million.

Deadline

  • Pre-Application / Letter of Intent: September 15, 2026 at 5:00 PM ET.
  • Full application: October 1, 2026 at 11:59 PM ET.
  • Application verification ends: October 6, 2026 at 5:00 PM ET.
  • Peer review: November 2026.
  • Programmatic review: January 2027.
  • Awards are expected to be made no later than September 30, 2027.

Further Information

  • Research may involve basic, translational, and/or clinical research in ovarian cancer.
  • Pre-applications are submitted through eBRAP; extramural organizations submit full applications through Grants.gov.
  • Official program page: View on Simpler.Grants.gov
  • Official FY26 Program Announcement: View the full guidelines